Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer
Open Access
- 27 June 2023
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research
- Vol. 25 (1) , 1-11
Abstract
FOXM1 (Forkhead box M1) is an oncogenic transcription factor that is greatly upregulated in breast cancer and many other cancers where it promotes tumorigenesis, and cancer growth and progression. It is expressed in all subtypes of breast cancer and is the factor most associated with risk of poor patient survival, especially so in triple negative breast cancer (TNBC). Thus, new approaches to inhibiting FOXM1 and its activities, and combination therapies utilizing FOXM1 inhibitors in conjunction with known cancer drugs that work together synergistically, could improve cancer treatment outcomes. Targeting FOXM1 might prove especially beneficial in TNBC where few targeted therapies currently exist, and also in suppressing recurrent advanced estrogen receptor (ER)-positive and HER2-positive breast cancers for which treatments with ER or HER2 targeted therapies that were effective initially are no longer beneficial. We present these perspectives and future directions in the context of what is known about FOXM1, its regulation, and its key roles in promoting cancer aggressiveness and metastasis, while being absent or very low in most normal non-regenerating adult tissues. We discuss new inhibitors of FOXM1 and highlight FOXM1 as an attractive target for controlling drug-resistant and difficult-to-suppress breast cancers, and how blocking FOXM1 might improve outcomes for patients with all subtypes of breast cancer.Keywords
Funding Information
- Breast Cancer Research Foundation (BCRF-083, BCRF-084)
- National Institutes of Health (1R01 CA220284, T32 GMO70421, 1R01 CA220284)
This publication has 96 references indexed in Scilit:
- The Forkhead Transcription Factor FOXM1 Controls Cell Cycle-Dependent Gene Expression through an Atypical Chromatin Binding MechanismMolecular and Cellular Biology, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- FoxM1 Regulates Mammary Luminal Cell FateCell Reports, 2012
- Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formationOncogene, 2011
- A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer CellsCancer Cell, 2011
- Forkhead Box M1 Transcription Factor Is Required for Macrophage Recruitment during Liver RepairMolecular and Cellular Biology, 2010
- Structure of the FoxM1 DNA-recognition domain bound to a promoter sequenceNucleic Acids Research, 2010
- FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistanceOncogene, 2010
- Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesisGenes & Development, 2009
- Chk2 Mediates Stabilization of the FoxM1 Transcription Factor To Stimulate Expression of DNA Repair GenesMolecular and Cellular Biology, 2007